Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 9,783,693,600
  • Shares Outstanding, K 82,650

Price Performance

See More
Period Period Low Period High Performance
1-Month
106.18 +11.38%
on 06/28/18
118.80 -0.45%
on 07/19/18
+4.36 (+3.83%)
since 06/20/18
3-Month
100.43 +17.75%
on 05/03/18
118.80 -0.45%
on 07/19/18
+13.30 (+12.67%)
since 04/20/18
52-Week
100.22 +18.00%
on 04/06/18
119.30 -0.87%
on 01/29/18
+10.62 (+9.87%)
since 07/20/17

Most Recent Stories

More News
What Investors Need to Know about Biotech ETFs

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

IBB : 118.26 (-0.08%)
FBT : 150.70 (+0.01%)
XBI : 100.13 (-0.27%)
What Investors Need to Know about Biotech ETFs

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

IBB : 118.26 (-0.08%)
FBT : 150.70 (+0.01%)
XBI : 100.13 (-0.27%)
Biotech ETFs Surge on Biogen's Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment.

PBE : 59.52 (-0.10%)
CELG : 85.10 (-0.28%)
IBB : 118.26 (-0.08%)
FBT : 150.70 (+0.01%)
BBH : 128.29 (-0.19%)
GILD : 77.37 (+0.42%)
AMGN : 190.49 (-0.66%)
BIIB : 358.71 (+0.17%)
Biotech ETFs Surge on Biogen's Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment.

PBE : 59.52 (-0.10%)
CELG : 85.10 (-0.28%)
IBB : 118.26 (-0.08%)
FBT : 150.70 (+0.01%)
BBH : 128.29 (-0.19%)
GILD : 77.37 (+0.42%)
AMGN : 190.49 (-0.66%)
BIIB : 358.71 (+0.17%)
Why Biotech Stocks Rallied on Biogen's Alzheimer's Test

Several major biotech stocks rallied on Friday after Biogen (BIIB) reported positive results from a Phase 2 study of its Ban2401 therapy, which seeks to reduce toxic amyloid proteins associated with cognitive...

CELG : 85.10 (-0.28%)
ESALY : 99.5525 (+0.20%)
IBB : 118.26 (-0.08%)
GILD : 77.37 (+0.42%)
AMGN : 190.49 (-0.66%)
BIIB : 358.71 (+0.17%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 46.53 (+0.45%)
SLDB : 43.11 (-2.27%)
BBC : 33.78 (-0.88%)
SBIO : 38.97 (+0.31%)
SRPT : 133.31 (-1.64%)
IBB : 118.26 (-0.08%)
VRTX : 177.40 (-1.51%)
ALNY : 105.93 (-0.31%)
XBI : 100.13 (-0.27%)
ALXN : 135.16 (+0.05%)
BIIB : 358.71 (+0.17%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 46.53 (+0.45%)
SLDB : 43.11 (-2.27%)
BBC : 33.78 (-0.88%)
SBIO : 38.97 (+0.31%)
SRPT : 133.31 (-1.64%)
IBB : 118.26 (-0.08%)
VRTX : 177.40 (-1.51%)
ALNY : 105.93 (-0.31%)
XBI : 100.13 (-0.27%)
ALXN : 135.16 (+0.05%)
BIIB : 358.71 (+0.17%)
Should You Invest in the PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)?

Sector ETF report for PBE

PBE : 59.52 (-0.10%)
ILMN : 311.15 (+0.66%)
IBB : 118.26 (-0.08%)
QGEN : 36.92 (-0.05%)
XBI : 100.13 (-0.27%)
BIIB : 358.71 (+0.17%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 33.78 (-0.88%)
CNCR : 25.05 (-0.32%)
IBB : 118.26 (-0.08%)
PSCH : 135.69 (-0.43%)
XBI : 100.13 (-0.27%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 33.78 (-0.88%)
CNCR : 25.05 (-0.32%)
IBB : 118.26 (-0.08%)
PSCH : 135.69 (-0.43%)
XBI : 100.13 (-0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 119.11
1st Resistance Point 118.68
Last Price 118.26
1st Support Level 117.90
2nd Support Level 117.55

See More

52-Week High 119.30
Last Price 118.26
Fibonacci 61.8% 112.01
Fibonacci 50% 109.76
Fibonacci 38.2% 107.51
52-Week Low 100.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar